section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypotension.

F and E: hyperkalemia.

GI: sprue-like enteropathy.

GU: impaired renal function.

Neuro: dizziness.

Misc: ANGIOEDEMA.

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

US Brand Names

Benicar

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: antihypertensives

Pharmacologic Classification: angiotensin II receptor antagonists

Pharmacokinetics

Absorption: Olmesartan medoxomil is a prodrug that is converted to olmesartan (the active component); 26% bioavailability of olmesartan.

Distribution: Crosses the placenta.

Protein Binding: 99%.

Metabolism/Excretion: No further metabolism following conversion of prodrug to active drug; 35–50% excreted unchanged in urine; remainder eliminated in feces via bile.

Half-life: 13 hr.

Canadian Brand Names

Olmetec

Time/Action Profile

(antihypertensive effect with chronic dosing)

ROUTEONSETPEAKDURATION
POwithin 1 wk2 wk24 hr

Patient/Family Teaching

Pronunciation

ole-me-SAR-tan me-DOX-o-mil

Pill Image

olmesartan_medoxomil_hcl_195_8688.jpg

Code

NDC Code*